Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMH9U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,630
Award facts
- Contract value 100% obligated
- $12,629.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,629.98 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors, with a completion deadline of December 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains an extensive portfolio of defense and veteran healthcare supply contracts.
This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. The IDC enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent is a biologic medication used to treat conditions such as atopic dermatitis and asthma, reflecting the company's capability to deliver specialty pharmaceutical products critical to military personnel and veteran care.
Quick answers
Who was awarded contract SPE2DR26FMH9U?
SPE2DR26FMH9U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FMH9U worth?
The government has obligated $12,630 on SPE2DR26FMH9U.
Is contract SPE2DR26FMH9U an order under another contract?
Yes. SPE2DR26FMH9U is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH9U competed?
The extent of competition for SPE2DR26FMH9U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award